Eplerenone for hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Eplerenone for hypertension

Published:2017-02-28 Issue:2 Volume:2017 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tam Tina SC¹,Wu May HY²,Masson Sarah C³,Tsang Matthew P⁴,Stabler Sarah N⁵,Kinkade Angus¹,Tung Anthony¹,Tejani Aaron M⁶

Affiliation:

1. Lower Mainland Pharmacy Services; Pharmacy; Vancouver BC Canada

2. Lower Mainland Pharmacy Services; Surrey Memorial Hospital Pharmacy; Surrey BC Canada

3. Fraser Health Authority; Pharmacy Services; 3938 Kincaid St Burnaby BC Canada V5G 1V7

4. Fraser Health Authority; Pharmacy Services; 32900 Marshall Road Abbotsford BC Canada V2S 0C2

5. Lower Mainland Pharmacy Services; Cardiac Clinics, Royal Columbian Hospital; Vancouver BC Canada

6. University of British Columbia; Therapeutics Initiative; 2176 Health Sciences Mall Vancouver BC Canada V6T 1Z3

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008996.pub2/epdf/full

Reference96 articles.

1. Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial;Calhoun;Circulation,2011

2. Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients;Flack;Journal of the American College of Cardiology,2003

3. Efficacy and safety of the selective aldosterone blocker eplerenone in Japanese patients with hypertension: a randomized, double-blind, placebo-controlled, dose-ranging study;Saruta;Journal of Clinical Hypertension (Greenwich),2004

4. Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension;Weinberger;American Journal of Hypertension,2002

5. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension;White;American Journal of Cardiology,2003

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of eplerenone in the FDA adverse event reporting system (FAERS) database: a focus on overall patient population and gender-specific subgroups;Frontiers in Pharmacology;2024-07-17

2. New ways of mitigating aldosterone in cardiorenal disease;European Heart Journal - Cardiovascular Pharmacotherapy;2024-07-10

3. Thermodynamic Analysis of Eplerenone in 13 Pure Solvents at Temperatures from 283.15 to 323.15 K;ACS Omega;2024-05-02

4. Current and emerging treatment options for central serous chorioretinopathy;Expert Review of Ophthalmology;2024-04-10

5. Redefining primary hyperaldosteronism as “The Syndrome of Inappropriate Aldosterone Secretion (SIALDS)”: A common but unrecognized cause of hypertension;The Journal of Clinical Hypertension;2023-10-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3